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Abstract
Alcoholic liver disease (ALD) is characterized by steato-
sis or fat deposition in the liver and inflammation, which 
leads to cirrhosis and hepatocellular carcinoma. Induc-
tion of target genes without involving changes in DNA 
sequence seems to contribute greatly to liver injury. 
Chromatin modifications including alterations in histones 
and DNA, as well as post-transcriptional changes col-
lectively referred to as epigenetic effects are altered by 
alcohol. Recent studies have pointed to a significant role 
for epigenetic mechanisms at the nucleosomal level in-
fluencing gene expression and disease outcome in ALD. 
Specifically, epigenetic alterations by alcohol include his-
tone modifications such as changes in acetylation and 
phosphorylation, hypomethylation of DNA, and altera-
tions in miRNAs. These modifications can be induced by 
alcohol-induced oxidative stress that results in altered 
recruitment of transcriptional machinery and abnor-
mal gene expression. Delineating these mechanisms in 
initiation and progression of ALD is becoming a major 
area of interest. This review summarizes key epigenetic 
mechanisms that are dysregulated by alcohol in the 
liver. Alterations by alcohol in histone and DNA modi-
fications, enzymes related to histone acetylation such 
as histone acetyltransferases, histone deacetylases and 
sirtuins, and methylation enzymes such as DNA methyl-
transferases are discussed. Chromatin modifications and 
miRNA alterations that result in immune cell dysfunction 
contributing to inflammatory cytokine production in ALD 
is reviewed. Finally, the role of alcohol-mediated oxida-
tive stress in epigenetic regulation in ALD is described. 
A better understanding of these mechanisms is crucial 
for designing novel epigenetic based therapies to ame-
liorate ALD.
© 2011 Baishideng. All rights reserved.
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INTRODUCTION
Chronic alcohol consumption has a significant impact 
on human health and is identified as a major risk factor 
for development of  liver disease. Alcoholic liver disease 
(ALD) is one of  the leading causes of  liver disease mor-
tality worldwide. Alcohol-related liver injury includes a 
spectrum of  pathological conditions in the liver including 
steatosis, steatohepatitis, cirrhosis and hepatocellular car-
cinoma. Of  the molecular mechanisms studied, epigenetic 
mechanisms altered by alcohol appear to play a significant 
role in development and progression of  disease. These 
mechanisms have been identified in parenchymal and 
non-parenchymal cells in the liver and contribute to in-
duction of  fatty liver, inflammation, as well as hepatocyte 
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apoptosis and necrosis. In the past decade, a number of  
studies have reported epigenetic alterations by alcohol in 
the liver including histone modification, DNA and his-
tone methylation derived from the methyl group donat-
ing system, S-adenosyl methionine (SAMe), miRNA as 
post-transcriptional modifiers, and chromatin remodeling 
enzymes responsible for epigenetic regulation such as 
histone acetyltransferases, histone deacetylases and DNA 
methyltransferases[1,2]. Defining an epigenetic imprint in 
alcohol-induced liver injury will provide new insights into 
pathophysiological mechanisms and open avenues for po-
tential novel epigenetics-based therapeutics. 
The goal of  this concise article is to review alcohol-
mediated epigenetic alterations, in parenchymal and non-
parenchymal cells of  the liver. Specifically, alcohol-mediat-
ed alterations in epigenetic enzymes, miRNAs as epigen-
etic modifiers, chromatin modifications affecting immune 
cell function in alcoholic liver, and the role of  oxidative 
stress in chromatin remodeling that regulates alcohol-
mediated gene expression in the liver are described.
THE EPIGENETIC CODE
The classical view defines epigenetics as heritable changes 
that affect gene expression without altering the DNA 
sequence. Epigenetic regulation of  gene expression is 
facilitated through different mechanisms such as DNA 
methylation, histone modifications, and RNA-associated 
silencing by small non-coding RNAs. All these mecha-
nisms are crucial for normal development, differentiation 
and tissue-specific gene expression. These three systems 
interact and stabilize one another and can initiate and 
sustain epigenetic silencing, thus determining heritable 
changes in gene expression. Alterations in one or more of  
these systems leads to inappropriate target gene expres-
sion or silencing that results in epigenetic regulation of  
human diseases such as cancer, autoimmune diseases, and 
age-related as well as neurological disorders[3,4]. Epigenetic 
abnormalities are diverse, tissue-specific and can occur 
due to various environmental factors such as toxins and 
drugs, including alcohol. 
Epigenetic regulation of  gene expression primarily 
works through modifying the secondary or tertiary struc-
tures of  DNA (chromatin), which makes it more or less 
accessible to transcription. Chromatin is made up of  re-
petitive structural units called nucleosomes. Nucleosomes 
are comprised of  a histone octamer and the DNA that 
wraps around it. Histones are globular basic proteins that 
are subject to various covalent modifications that occur 
primarily on the N-terminal tail[5]. The histone octamer 
contains two molecules of  each of  the histones H2A, 
H2B, H3 and H4, around which the DNA wraps. Histone 
H1 the “linker histone” along with “linker DNA” physi-
cally connects the adjacent nucleosome core particles. Co-
valent histone modifications appear to act sequentially or 
in combination to form a recognizable code that is identi-
fied by specific proteins to regulate distinct downstream 
events such as transcriptional activation or repression[5]. 
Histones are subject to various post-translational modifi-
cations such as acetylation, methylation, phosphorylation, 
ubiquitinylation and sumoylation, all having an impact on 
gene transcription[5]. Histone acetylation is a transcription-
activating modification that is achieved by addition of  
acetyl groups to lysine residues by enzymes called histone 
acetyltransferases (HATs). The major sites of  acetylation 
in histone H3 are Lys4, Lys9, Lys14 and Lys28. Acetyl 
groups are removed by histone deacetylases (HDACs) and 
this is generally associated with loss of  gene expression or 
silencing[6]. Mammalian HDACs have been classified into 
four classes. Class Ⅰ HDACs (1, 2, 3 and 8) are found pre-
dominantly in the nucleus, whereas Class II HDACs (4 5, 
6, 7, 9 and 10) shuttle between the nucleus and cytoplasm. 
Class Ⅰ and Class Ⅱ HDACs have tissue-specific expres-
sion profiles. HDACs 1, 2 and 3 are expressed in various 
immune cells[ 7]. Class Ⅲ HDACs (SIRT1-SIRT7) form a 
distinct class of  NAD-dependent enzymes, can be inhibit-
ed by nicotinamide, and are important in DNA repair and 
anti-apoptotic functions[8]. HDAC 11 possesses properties 
of  Class Ⅰ and Ⅱ HDACs and is classified as Class Ⅳ. 
Table 1 illustrates the histone modifications and enzymes 
linked to the changes. 
Histone methylation is catalyzed by histone methyl-
transferases at lysine and arginine residues on histone H3 
and H4 and can be mono-, di- and tri-methylated. The 
major sites on histone H3 are Lys4, Lys9, Lys27, Lys36 
and Lys79, whereas histone H4 is methylated on Lys20[5]. 
The methyl group donor is S-adenosyl methionine. The 
effects of  alcohol exposure on SAMe-mediated epigenetic 
changes have been under investigation[9]. Arginine meth-
ylation is transcription-activating, and lysine methylation 
can cause either transcriptional activation or repression, 
depending on the lysine residue methylated. For instance, 
H3K9 can be acetylated as well as methylated and have 
opposite transcriptional consequences; H3AcK9 causes 
transcriptional activation whereas H3K9me (mono-, 
di- and tri-) leads to transcriptional repression. Thus, a 
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Table 1  Histone modifications, enzymes and genes
Modifications Enzymes Target gene transcription
Acetylation
H3 GNAT Activating
H4 MYST Activating
H3 and H4 CBP/p300 Activating
Deacetylation
H3 and H4 HDACs 1-11 Silencing
Methylation
H3K4 Set1 Activating
H3K36 Set2 Activating
H3K79 DoT1L Activating
H3K27 EZH2 Silencing
H3K9 SUV39H1 Silencing
H4K20 SUV4-20H1 Silencing
Phosphorylation
H3S10 RSK2 Silencing
Methylated CpG DNMT1, DNMT3a-3b Silencing
balance in H3K9 acetylation and methylation may be im-
portant in determining chromatin architecture and gene 
silencing or activation[5]. 
Histone phosphorylation is a transcription-activating 
modification achieved by kinases that catalyze the transfer 
of  a phosphate group from ATP or GTP to the serine or 
threonine residue of  histone H3. Besides phosphoryla-
tion, histone H1, H2A, H2B and H3 can be ubiquitinated 
at lysine residues that activate transcription. Sumoylation 
on the other hand occurs on lysine residues and is a tran-
scriptionally repressive modification. 
DNA methylation involves transfer of  a methyl group 
to cytosine bases at the C5 position of  CG dinucleotides, 
referred to as CpG dinucleotides, and may occur in clus-
ters, known as CpG islands. By definition, CpG islands are 
genomic regions that are at least 200 base pairs long, with 
≥ 50% GC content and ≥ 60% expected CpG ratio[10]. 
The methyl donor is SAMe and the enzyme involved is 
DNA methyltransferase (DNMT). Two groups of  mam-
malian DNMTs, one that de novo methylates DNA, and the 
other that maintains the methylation status, are classified 
as four different types: DNMT 1, 2, 3A and 3B. Although 
DNMT 3A and 3B are de novo methylation enzymes[11], 
DNMT 1 maintains methylation status, whereas the func-
tion of  DNMT 2 is not yet clear and it has weak methyl-
transferase activity. DNA methylation leads to transcrip-
tional silencing due to chromatin condensation, increased 
recruitment of  methylated CpG binding transcriptional 
repressor, and inhibition of  DNA binding of  transcrip-
tional activators[11]. The unmethylated CpG islands are as-
sociated with transcriptionally active promoters, and how 
CpG islands remain unmethylated is still unclear[12].
Non-coding RNA (ncRNA) is another mechanism of  
epigenetic regulation and is driven by long or small ncRNAs. 
Long ncRNAs such as Air[13], Kcnq1ot1[14] and H19[15] exert 
their epigenetic effect by genomic imprinting, which involves 
DNA methylation. On the other hand, small ncRNAs such 
as miRNA affect translational repression of  mRNA, mRNA 
degradation, DNA methylation, and chromatin modifica-
tion[16]. miRNAs are short [~22 nucleotides(nt)] ncRNAs that 
regulate gene expression by binding to their cognate binding 
sites at the 3’-end of  the target mRNA, and inhibiting their 
translation. miRNAs are transcribed from miRNA genes 
mostly by RNA polymerase Ⅱ into long primary miRNA 
(pri-miRNA) transcripts that often contain thousands of  
nucleotides and form hairpins (stem loops). The pri-miRNA 
is processed in the nucleus by Drosha-DGCR8 complex to 
produce 70-80-nt precursor miRNA (pre-miRNA)[16]. Pre-
miRNAs are transported from the nucleus to the cytoplasm 
by exportin-5 and Ran-GTP complex, where they are further 
processed into ~22-nt long miRNA/miRNA duplex by 
Dicer, a RNAse type Ⅲ enzyme. One of  the miRNA strands 
bind to the cognate binding site on the target mRNA with 
a ~2-nt mismatch, and it is binding of   the RNA silencing 
complex at the 3’ UTR of  the target mRNA that represses 
its translation and results in gene silencing[16].
The crosstalk between various epigenetic mechanisms 
described above can determine downstream chromatin 
remodeling and gene expression. Mechanisms such as his-
tone acetylation and methylation, DNA methylation and 
ncRNA-mediated modifications, are acquired throughout 
life, and persist, and influence the ability to deal with envi-
ronmental factors such as nutritional factors, toxicants 
and lifestyle-related factors including tobacco smoke, 
alcohol, chemical carcinogens, infectious agents and 
UV radiation, thus influencing the clinical outcomes of  
health and disease[17].
EPIGENETIC DYSREGULATION IN ALD
The emerging role of  epigenetic regulation of  gene ex-
pression by alcohol and its effect on organ injury comes 
from studies in the past decade[1,2]. Here, we review mech-
anisms related to histone modifications and DNA meth-
ylation induced by alcohol exposure in liver cells, which 
contribute to ALD.
Histone modifications: acetylation, phosphorylation and 
methylation
Multiple lines of  evidence from in vitro and in vivo studies 
have established that alcohol induces epigenetic modi-
fications in various organs including the gastrointestinal 
system, brain and liver[2]. In the liver, alcohol alters histone 
acetylation, methylation as well as phosphorylation. Selec-
tive acetylation of  histone H3 at lys 9 (H3AcK9) has been 
observed in primary rat hepatocytes exposed to alcohol in 
vitro[18]. On the other hand, other lysine residues H3 lys14, 
lys18 and lys23 were not acetylated. In the liver, H3 acety-
lation was modulated by alcohol via increased HAT activ-
ity and HDAC inhibition[19]. 
The status of  histone acetylation depends on the 
activity of  HAT and HDAC[20]. In some instances, the 
balance of  HAT/HDAC ratio determines the acetylation 
of  histone residues and influences gene expression[21]. Al-
cohol exposure appears to alter HAT and HDAC activity 
in hepatocytes[19]. In vitro alcohol exposure of  hepatic cells 
impairs HDAC6 function, which directly affects micro-
tubule dynamics[22]. The mRNA expression of  class Ⅲ 
HDAC, sirtuin 1 (SIRT1) is reduced in alcohol-exposed 
hepatocytes[23]. Furthermore, an essential role for SIRT1 
in mediating effects of  alcohol on SREBP-1 and hepatic 
lipid metabolism in alcoholic fatty liver has been report-
ed[24]. These results indicate that SIRT1 can be developed 
as a therapeutic target in ALD. Overall, alcohol seems to 
influence HATs and HDACs in hepatocytes. Studies are 
needed to determine the precise role of  these altered en-
zyme activities in the context of  ALD in vivo. 
Similar to acetylation, phosphorylation of  histones 
is crucial to chromatin modifications, and activates gene 
transcription downstream of  cell signaling events[25]. Acute 
alcohol exposure modulates H3 phosphorylation at serine 
10 and serine 28 in rat hepatocytes, and this is dependent 
on p38 mitogen-activated protein kinase activity but not 
extracellular signal-regulated kinase and C-Jun N-terminal 
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kinase[26]. Recent studies also have indicated that in vivo 
acute alcohol exposure induces H3 serine-10 and serine-28 
phosphorylation which was transiently increased at 1 h, 
but decreased at 4 h after alcohol administration[27]. On 
the other hand, persistent H3K9 acetylation in the liver 
was observed at 4 h after acute alcohol exposure in vivo[27]. 
A relationship between acetylation and phosphorylation 
in context with gene activation has been examined[25]. For 
instance, cytokine-induced gene expression mediated by 
nuclear IKKα leading to nuclear factor (NF)-κB activa-
tion involves coupling of  H3 phosphorylation at serine 
10 and acetylation at lysine 14[28,29]. On the other hand, 
retinoic acid receptor-β and c-jun gene regulation is linked 
to phosphorylation of  histone H3 and not acetylation, 
which indicates that these two epigenetic changes can oc-
cur independently[30-32]. Whether alcohol induces histone 
phosphorylation and acetylation synergistically or as in-
dependent pathways to regulate target gene expression in 
ALD remains to be investigated.
Specific methylated lysine residues on histones func-
tion as stable epigenetic marks that direct particular bio-
logical functions, ranging from transcriptional regulation 
to heterochromatin assembly[33]. Histone methyltransferas-
es catalyze transfer of  a methyl residue predominantly to 
H3 and H4 histones that impart biological functions such 
as transcription or epigenetic silencing[33]. Shukla et al[34] 
have shown differential methylation of  H3 and H4 in rat 
hepatocytes exposed to alcohol in vitro. These studies have 
indicated that methylation at H3meLys9 is decreased and 
is associated with downregulation of  genes such as Lsdh, 
whereas increased methylation of  H3meLys4 is associated 
with upregulation of  alcohol dehydrogenases (ADH1)[34]. 
Whether acute or chronic alcohol-mediated histone meth-
ylation serves as a stable genomic imprint that determines 
the transcriptional state of  a gene contributing to disease 
is still unknown. 
DNA methylation in ALD
Methylation of  cytosine at C5 in the CpG dinucleotides 
silences transcription, whereas absence of  methylation ac-
tivates transcription. Although 80% of  CpG dinucleotides 
are methylated, unmethylated CpG residues in promoter 
regions of  constitutively active genes are referred to as CpG 
islands[35]. The predominant methyl donor, SAMe, which is 
important in DNA methylation, is depleted in alcoholic liv-
ers, which results in hyperhomocysteinemia that is common-
ly observed in patients with ALD[36]. Decreased SAMe in 
alcoholic livers also seems to affect DNA methylation. Rats 
fed an intragastric alcohol diet for 9 wk exhibited decreased 
methionine, SAMe, glutathione and loss of  DNA methyla-
tion by 40%[37]. This DNA hypomethylation can lead to al-
teration in gene expression and chromatin structure, results 
in increased DNA damage and strand breaks[37,38], which 
predisposes cells to malignant degeneration[39]. An associa-
tion between alcohol intake and hypomethylation of  the 
O6-methylguanine DNA methyltransferase gene has been 
noted in context with hepatocellular carcinoma[40]. Studies 
also have shown that alcohol-metabolizing enzyme, ADH1, 
is regulated by epigenetic mechanisms in hepatoma cells 
involving DNA hypomethylation[41]. In addition to direct ef-
fects of  alcohol on DNA hypomethylation, direct effects of  
acetaldehyde on DNA methyltranferase[42] and methionine 
synthase[43,44] have been reported. Whether alcohol directly 
alters DNA methyltranferase activity and methionine syn-
thase is yet unknown. Chronic alcohol consumption induces 
global DNA hypomethylation[45], whereas hypermethylation 
of  DNA is observed in human peripheral blood cells after 
alcohol consumption in humans[46,47]. Alcohol-associated 
hypomethylation thus far is linked to decrease in SAMe, the 
methyl donor. 
An interplay between histone acetylation and DNA 
methylation is involved in the process of  gene transcrip-
tion and/or silencing in diseased states[17]. For instance, 
hypermethylation of  CpG islands in target gene promoters 
triggers deacetylation of  local histones, whereas lower lev-
els of  histone acetylation seem to sensitize DNA to meth-
ylation. Although there is an intimate communication be-
tween these two epigenetic phenomena, it is still not clear 
whether there is any hierarchical order of  these events. In 
chronic alcohol exposed livers, whether an interconnection 
exists between hyperacetylation of  H3K9, loss of  methyla-
tion of  H3K9, and increased methylation of  H3K4, along 
with global hypomethylation of  DNA is unknown. Studies 
undertaken to identify the interplay of  epigenetic events 
will provide new insights into mechanisms of  ALD.
miRNAs AS EPIGENETIC MODULATORS 
IN ALD  
The role of  miRNAs as epigenetic modulators is appar-
ent from its regulation of  gene expression at the post-
transcriptional level. miRNAs elicit degradation of  target 
mRNA or hinder translational mechanisms such as initia-
tion, elongation, degradation or segregation of  mRNA 
into P bodies for translational inhibition[48-50]. The impor-
tance of  miRNAs in liver diseases such as viral hepatitis, 
alcoholic fatty liver disease and non-alcoholic fatty liver 
disease (NAFLD), fibrosis, and hepatocellular carcinoma 
has recently been recognized[51]. Studies have shown that 
alcohol exposure regulates miRNAs that control post-
transcriptional events and influence gene expression that 
are important in ALD[52]. miRNAs have been linked to 
lipid metabolism and inflammation in steatohepatitis[53-56]. 
Dolganiuc et al[52] have shown that alcohol feeding in-
creases and decreases ~1% of  known miRNA, whereas 
methionine/choline-deficient diet upregulates 3% and 
reduces 1% of  known miRNAs. Common to ALD and 
NAFLD, miR-705 and miR-122 are increased with both 
diets. However, miR-182, miR-183 and miR-199a-3p 
are increased in NAFLD and decreased in ALD mouse 
models. The functional relevance of  miRNAs in ALD 
and NAFLD remains to be determined. Using hepatocyte 
cultures, recent studies have shown that ~11 miRNAs are 
altered in hepatic lipid droplets[57]. MiR-181d is the most 
efficacious inhibitor and reduces lipid droplets by 60%, 
which confirms its role in cellular synthesis of  triglycerides 
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and cholesterol esters[57]. More recent studies have shown 
that chronic alcohol induces miRNA-155 in liver macro-
phages[58]. Chronic alcohol exposure also alters miRNAs 
that affect intestinal permeability[59]. Alcohol intake results 
in induction of  miR-212, which in turn downregulates 
tight junction protein zonula occludens 1[59]. miRNA-212 
is also higher in colon biopsy samples of  patients with 
ALD, which confirms the pathophysiological significance 
of  miRNA-212 in altering intestinal permeability during 
ALD. The role of  miRNAs as epigenetic modulators of  
gene expression and silencing is becoming evident in ALD. 
An improved understanding of  miRNAs and subsequent 
post-transcriptional regulatory mechanisms will be of  
importance in advancing their application as diagnostic or 
prognostic markers, as well as therapeutic targets in ALD.
EPIGENETICS AND INFLAMMATION IN 
ALD
The first report on aberrations in the epigenetic code in 
an inflammatory disease condition such as rheumatoid 
arthritis was reported in 1990[60]. Anti-inflammatory effects 
of  HDAC inhibitors used in a number of  experimental 
models of  inflammatory diseases have confirmed a role 
for epigenetics in immune function[61-63]. Epigenetic regula-
tory mechanisms are central to the immune response, al-
lowing an appropriate gene expression pattern in immune 
cells[64,65]. Environmentally regulated or endogenously 
mediated epigenetic alterations contribute to environment-
host interactions in various forms of  inflammatory dis-
eases[66].
Innate immune responses and macrophage function 
play a central role in ALD[67,68]. Epigenetic modifications 
that influence inflammatory responses have been reported 
in macrophages[69] during lipopolysaccharide (LPS) toler-
ance. This phenomenon is dependent on histone acetyla-
tion and H3K4 methylation, as well as chromatin remodel-
ing enzymes such as SW1/SNF[70]. Acute alcohol exposure 
decreases LPS induced proinflammatory responses in 
human monocytes[71,72]. Whether acute alcohol mediates 
histone modifications and recruitment of  nucleosome re-
modeling enzymes at  the promoters of  the cytokine genes 
is yet to be determined. 
The transcription factor NF-κB is a master regulator 
of  proinflammatory responses in macrophages and mono-
cytes[73,74]. It is the organization of  the chromatin structure 
that controls the kinetics of  NF-κB recruitment to target 
gene promoters that represents a focal point in media-
tion of  transcription cooperativity (Figure 1). Acute and 
chronic alcohol exposure modulates NF-κB DNA binding 
that regulates expression of  proinflammatory cytokines 
such as tumor necrosis factor (TNF)-α, interleukin (IL)-
1β and IL-6[68,75]. A tailored immune response that is regu-
lated by NF-κB via interaction with HATs and HDACs 
elicits epigenetic modifications[76]. For instance, HDAC-1 
is known to form a complex with NF-κBp50 homodi-
mers to repress gene transcription[77]. On the other hand, 
inflammatory stimuli such as LPS can induce phospho-
acetylation of  histone H3 (K9/S10) at a subset of  cytokine 
and chemokine gene promoters for increased NF-κB re-
cruitment[29,78,79]. Reductions in H3 Lys9 methylation, along 
with increased H3/H4 acetylation are strongly correlated 
with RNA polymerase II recruitment, which results in 
transcription of  NF-κB-inducible inflammatory genes[79]. 
Whether alcohol exposure affects epigenetic mechanisms 
to prolong or reduce DNA binding of  NF-κB to the cy-
tokine gene promoters in monocytes and macrophages 
is not yet known. Another environmental agent, cigarette 
smoke induces post-translational modification of  phos-
pho-deacetylases, HDAC2 and SIRT1, acetylation of  p65-
NF-κB and phosphoacetylation of  histone H3 that leads 
to chromatin rearrangement and sustained proinflamma-
tory gene transcription[80,81]. It is likely that chronic alcohol 
exposure modulates HDAC2 and SIRT1 in immune cells 
to regulate epigenetic events that promote prolonged pro-
inflammatory responses in ALD.
In macrophages stimulated with viruses or bacteria, 
miRNA-155 is the only increased miRNA induced by both 
stimulants[82,83]. miRNA-155 regulates TNF-α production 
positively by enhancing its translation[84]. Bala et al[58] re-
cently reported that chronic alcohol induces miRNA-155 
in an NF-κB-dependent manner that increases mRNA 
stability and TNF-α expression in ALD. miR-146 is pre-
dominantly expressed in T regulatory and Th1 cells[85] and 
is upregulated in toll-like-receptor-stimulated macrophages 
in an NF-κB-dependent manner. miR-146 targets IRAK-1 
and TRAF6 genes and is unaffected by chronic alcohol 
exposure in liver immune cells[58]. Overall, these findings 
suggest that miRNAs are capable of  regulating alcohol-
induced innate immune cell function and thus determining 
cellular memory via miRNA-mediated epigenetic modu-
lation. 
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Figure 1  Epigenetic regulation of gene expression via histone modifica-
tion. Under normal conditions, activation of histone deacetylases (HDACs) 
inhibits acetylation (Ac) of histones, which results in chromatin packaging, 
restriction of DNA accessibility for transcription, and controlled target gene ex-
pression. During alcohol exposure, histone modifications mediated by histone 
acetyltransferases (HATs) influence elevated transcription of target genes, 
due to chromatin accessibility, which leads to increased DNA occupancy of 
transcription factors such as nuclear factor-κB (p50/p65), co-activators and 
transcriptional complexes, and elevated target gene expression.
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ALCOHOL, OXIDATIVE STRESS AND 
CHROMATIN REMODELING
Oxidative stress regulates chromatin remodeling by al-
teration of  histone acetylation and deacetylation events 
via HAT/HDAC activity[86,87]. Acute and chronic alcohol 
exposure increases reactive oxygen species (ROS) produc-
tion and lowers antioxidant levels that enhance oxidative 
stress in the liver[88]. Metabolism of  alcohol through al-
cohol dehydrogenase and microsomal cytochrome P450 
2E1 leads to enhanced production of  ROS in the liver[88]. 
Acetylation of  histone H3 by alcohol in rat hepatocytes 
is mediated by ROS[89]. Inhibition of  NADPH-oxidase-
mediated ROS results in decreased H3AcK9, whereas 
ROS inducers directly increase alcohol-induced acetyla-
tion of  H3K9, along with induction of  ADH1 mRNA 
expression[89]. A redox-sensitive class III HDAC molecule, 
SIRT1, is also decreased in alcohol-exposed rat hepato-
cytes and livers of  alcohol-fed rats[24]. Whether alcohol-
induced ROS[90] play an important role in modulation of  
SIRT1 to regulate steatosis remains to be determined. In 
addition to alcohol, acetaldehyde and acetate, which are 
products of  alcohol metabolism, cause acetylation of  
H3K9. Pyrazole, an inhibitor of  alcohol dehydrogenase 
and methyl cyanamide, an inhibitor of  aldehyde dehydro-
genase, both reduce H3K9 acetylation, which indicates 
that alcohol and its metabolites can trigger acetylation 
of  histone residues. Similar to in vitro observations, in 
vivo acute alcohol exposure in rats also shows that H3K9 
acetylation is significantly increased in the liver[91]. Studies 
have shown that H3K9 acetylation in hepatocytes due to 
alcohol exposure correlates with transcriptional increase in 
alcohol dehydrogenase (ADH1)[19]. It is likely that alcohol-
induced acetylation is required for activation of  alcohol-
metabolizing enzymes, which induce oxidative stress. This, 
in turn, induces acetylation that creates an amplifying “au-
tocrine loop” between alcohol metabolism and epigenetic 
events. Future studies to determine the precise role of  
alcohol-mediated oxidative stress in chromatin modifica-
tions in hepatocytes and liver macrophages will identify 
new pathophysiological mechanisms and epigenetic tar-
gets of  gene expression in ALD.
Stress-induced heat shock transcription factor (HSF)1 
plays an important role as a transcriptional repressor of  
proinflammatory cytokine genes[92,93]. Recent studies have 
suggested that HSF1 serves as a master regulator of  glob-
al acetylation in normal cells, whereas, in stressed cells, 
HSF1 interacts with HDAC1 and HDAC2, which induce 
histone deacetylation and chromatin remodeling[94]. Stud-
ies from our laboratory have shown that alcohol exposure 
induces HSF1 DNA binding activity in monocytes and 
macrophages[95]. Whether alcohol-induced HSF1 induces 
chromatin reorganization that affects proinflammatory 
cytokine production is being investigated. Another key 
stress-induced molecule, heat shock protein (hsp)90, is 
characterized as an epigenetic “gatekeeper” that interfaces 
with the environment and may finally determine whether 
certain epigenetic markers succeed in downstream pheno-
typic expression[96-98]. Chronic alcohol exposure upregu-
lates hsp90 expression in liver macrophages[95]. It is likely 
that hsp90 facilitates an alcohol-mediated “epigenetic 
code” in the liver. Studies to delineate epigenetic effects 
of  alcohol-induced hsp90 on gene transcription in liver 
macrophages and hepatocytes are awaited. 
Hydroxyl radicals generated by oxidative stress inter-
fere with the ability of  DNA to function as a substrate 
for DNMT, which results in global hypomethylation[99,100]. 
Recent studies have provided evidence for the role of  en-
doplasmic reticulum stress pathways and epigenetic gene 
regulation[101]. It is likely that alcohol-mediated oxidative 
stress regulates epigenetic markers in ALD. 
CONCLUSION
The interplay of  epigenetic mechanisms and their influ-
ence on gene transcription in ALD is evolving. Epigen-
etic alterations associated with acute and chronic alcohol 
exposure of  hepatocytes and immune cells in relation 
to ALD is discussed in this review. Studies thus far have 
shown that alcohol exposure, probably via oxidative stress, 
exhibits differential regulation of  acetylation, phosphory-
lation and methylation of  histones that regulate chromatin 
remodeling and gene expression. The effects of  alcohol 
on DNA methylation in hepatocytes and miRNA regula-
tion have been elucidated. An integrative approach of  the 
various mechanisms that lead to genomic imprinting dur-
ing alcohol exposure will identify novel pathways in the 
alcoholic liver and support epigenetic therapeutic inter-
ventions. 
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